Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 107, Issue 8, 2013, Pages 465-470

  Valerio, Lluís ^a   Roure, Sílvia ^a   Fernández Rivas, Gema ^b   Basile, Luca ^c   Martínez Cuevas, Octavio ^a   Ballesteros, Ángel Luis ^d   Ramos, Xavier ^e   Sabrià, Miquel ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Generalitat of Catalonia ^*  (Spain)

^d Hospital Municipal de Badalona   (Spain)

^e HOSPITAL DE L ESPERIT SANT   (Spain)

Author keywords

Eosinophilia; Immigrants; Immune suppression; Intestinal parasites; Ivermectin; Strongyloides stercoralis

Indexed keywords

ALBENDAZOLE; IVERMECTIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMIGRANT; IMMIGRATION; MAJOR CLINICAL STUDY; MALE; RELAPSE; SIDE EFFECT; SPAIN; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EOSINOPHILIA; IMMIGRANTS; IMMUNE SUPPRESSION; INTESTINAL PARASITES; IVERMECTIN; STRONGYLOIDES STERCORALIS;

ADULT; ANIMALS; ANTHELMINTICS; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IVERMECTIN; MALE; PREVALENCE; SENTINEL SURVEILLANCE; SPAIN; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; YOUNG ADULT;

EID: 84881225504     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt053     Document Type: Article

References (36)

1. Igual-Adell R, Domínguez-Márquez V. Estrongiloidiasis: epidemiología,manifestaciones clínicas y diagnóstico. Experiencia en una zonaendémica. La comarca de La Safor (Valencia). Enferm Infecc MicrobiolClin 2007;25:38-44.
2. CDC, DPDx. Parasites and health: Strongyloidiasis. Centers for DiseaseControl & Prevention; 2009. http://www.dpd.cdc.gov/dpdx/hTML/Strongyloidiasis.htm (accessed 4 November 2012).
3. Grove DI. Human strongyloidiasis. Adv Parasitol 1996;38:251-309.
4. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophilcount in the diagnosis and management of strongyloidiasis in anon-endemic area. Am J trop Med Hyg 2002;66:749-52.
5. Eriksson CD, Steffens R, Siddiqui AA, Berk SL. Diagnosis of Strongyloidesstercoralis infection. Clin Infect Dis 2001;33:1040-7.
6. Brooker S, Clements AC, Brundy DA. Global epidemiology, ecology andcontrol of soil-transmitted helminth infections. Adv Parasitol 2006;62:221-61.
7. Nozais JP, Thelier M, Datry A, Danis M. Disseminated strongyloidiasis.Presse Med 2001;30:813-8.
8. IDESCAT. Demographic data on Catalonia municipalities 2010. http://www.idescat.cat/territ/basicterr?TC=5&V0=NC&V3=863&V4=435&ALLINFO=TRUE&PARENT=1&CTX=B&lang=es (accessed 4 November2012).
9. Gotlib J.World Health Organization-defined eosinophilc disorders:2012update on diagnosis, risk stratification andmanagement. AmJ Hematol2012;87:903-14.
10. Montes M, Sauhney C, Barros N. Strongyloides stercoralis: there but notseen. Curr Opin Infect Dis 2010;23:5040-4.
11. Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfectionsyndrome: an emerging global infectious disease. Trans R SocMed Trop Hyg 2008;102:314-8.
12. Abrescia F, Falda A, Caramaschi G et al. Reemergence of strongyloidiasis,northern Italy. Emerg Infect Dis 2009;15:1531-3.
13. Mirdha B.Humanstrongyloidiasis: often brushed under the carpet. TropGastroenterol 2009; 30:1-4.
14. Mascarello M, Gobbi F, Angheben A et al. Prevalence of Strongyloidesstercoralis infection among HIV-positive immigrants attending in twoItalian hospitals, from 2000 to 2009. Am Trop Med Med Parasitol2011;105:617-23.
15. Biggs B, Caruana S, Mihrshahi S et al. Management of chronic strongyloidiasisin immigrants and refugees: is serologic test useful? Am J TropMed Hyg 2009;80:788-91.
16. Verweij J, Canales M, Polman K et al. Molecular diagnosis of Strongyloidesstercoralis in faecal samples using real-time PCR. Trans R SocTrop Med Hyg 2009;103:342-6.
17. Ramanathan R, Burbelo PD, Groot S et al. A luciferase immunoprecipitationsystems assay enhances the sensitivity and specificity ofdiagnosis of Strongyloides stercoralis infection. J Infect Dis 2008;198:444-51.
18. Requena-Méndez A, Chiodini P, Bisoffi Z et al. The laboratory diagnosisand follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis2013;7:e2002. doi: 10.1371/journal.pntd.0002002. Epub 2013 Jan 17.
19. Olsen A, van Lieshout L, Marti H et al. Strongyloidiasis-the mostneglected of the neglected tropical diseases? Trans R Soc Trop MedHyg 2009;103:967-72.
20. Roman P, Pastor A, Moreno S et al. Endemicstrongyloidiasisonthe SpainMediterranean coast. QJ Med 2001;94:357-63.
21. Hochberg NS, Moro RN, Sheth AN et al. High prevalence of persistentparasite infections in foreign-born HIV persons in United States. PLoSNegl Trop Dis 2011; 5:e1034.
22. Boulware DR, Stauffer WM, Hendel-Patterson DR et al. Maltreatment ofStrongyloides infection: case-series and worldwide physicians-intrainingsurvey. AmJ Med 2007;120:545.e1-8.
23. Sudarshi S, Stümpfle R, Armstrong M et al. Clinical presentation anddiagnostic sensitivity of laboratory tests for Strongyloides stercoralisin travelers compared with immigrants in a non-endemic country.Trop Med Int Health 2003;8:728-32.
24. González A, Gallo M, Valls ME et al. Clinical and epidemiological featuresof 33 imported Strongyloides stercoralis infections. Trans R Soc TropMedHyg 2010;104;613-6.
25. Checkley AM, Chiodini PL, Dockell DH et al. Eosinophilia in returningtravelers and migrants from the tropics: UK recommendations forinvestigation and initial management. J Infect 2010;60:1-20.
26. Vaiyavatmai P, Boitano JJ, Techasintana P, Tungtrongchitr A.Immuno-compromised group differences in the presentation ofintestinal strongyloidiasis. Jpn J Infect Dis 2008;61:5-8.
27. Assefa S, Erko B, Mehdin G et al. Intestinal parasitic infections in relationto HIV/AIDS status, diarrhea and CD4-T cell count. BMC Infect Dis2009;9:155.
28. Masucci L, Graffeo R, Bani S et al. Intestinal parasites isolated in a largeteaching hospital, Italy, 1May 2006 to 31 December 2008. Euro Surveill2011;16:pii - 19891.
29. Alvarez-Martinez M, Valls ME, Aldasoro J et al. Prevalence ofstrongyloidiasis and Chagas' disease co-infection in Latin-Americanmigrants in a tertiary hospital in Spain. 22nd European Congress of ClinicalMicrobiology and Infectious Diseases (ECCMID), London, 31.03.2012-03.04.2012. http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=144208&XNSPRACHE_ID=2&XNKONGRESS_ID=161&XNMASKEN_ID=900 (accessed 11 Nov 2012).
30. Croker C, Reporter R, Redelings M, Mascola L. Strongyloidiasis-relateddeaths in united States 1991-2006.AmJ TropMedHyg 2010;83:422-6.
31. Iriemenam NC, Sanyaolu AO, Oyibo WA, Fagbenro-Beyioku AF.Strongyloides stercoralis and the immune response. Parasitol Int.2010;59:9-14. Epub 2009 Nov 3.
32. Vilela EG, Clemente WT, Mira RR et al. Strongyloides stercoralishyperinfection syndrome after liver transplantation: case report andliterature review. Transpl Infect Dis 2009;11:132-6.
33. Siegel MO, Simon GL. Is Human Immunodeficiency Virus infection a riskfactor for Strongyloides stercoralis hyperinfection and dissemination?PLoS Negl Trop Dis 2012;6:e1581.
34. Datry A, Hilmardottir I, Mayorga-Sagastume R et al. Treatment ofStrongyloides stercoralis infection with ivermectin compared withalbendazole: results of an open study of 60 cases. Trans R Soc MedTrop Hyg 1994;88:344-5.
35. Bisoffi Z, Buonfrate D, Angheben A et al. Randomized clinical trial onivermectin versus thiabendazole for the treatment of strongyloidiasis.PLoS Negl Trop Dis 2011;5:e1254.
36. Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, Beeching NJ.Efficacy and safety of a single-dose veterinary preparation ofivermectin versus 7-day high-dose albendazole for chronicstrongyloidiasis. Int J Antimicrobiol Ag 2008;31:46-9.